预激综合征合并房颤60例治疗临床分析  

Clinical analysis on treatment of 60 patients with pre-excitation syndrome compound atrial fibrillation

作　　者：于亚男[1] 马洪滨 

机构地区：[1]大连市友谊医院心内科,116001 [2]大连金州区第一人民医院急诊科

出　　处：《中国现代药物应用》2017年第1期118-119,共2页Chinese Journal of Modern Drug Application

摘　　要：目的对预激综合征合并心房颤动(房颤)患者的治疗效果进行分析。方法 60例预激综合征合并房颤患者,根据治疗药物不同分为盐酸普罗帕酮组,胺碘酮组,利多卡因组和盐酸维拉帕米组,各15例。各组使用相应药物治疗,比较各组药物复律疗效。结果盐酸普罗帕酮组复转率80.00%和胺碘酮组复转率73.33%高于盐酸维拉帕米组的33.33%和利多卡因组的33.33%,差异有统计学意义(P<0.05)。结论在预激综合征合并房颤的治疗中,首先使用盐酸普罗帕酮或胺碘酮治疗明显优于使用盐酸维拉帕米或利多卡因,可有效复律,挽救患者的生命。Objective To analyze therapeutic effect of patients with pre-excitation syndrome compound atrial fibrillation. Methods A total of 60 patients with pre-excitation syndrome compound atrial fibrillation were divided by different therapeutic drugs into propafenone hydrochloride group, amiodarone group, lidocaine group and verapamil hydrochloride group, with 15 cases in each group. Every group received corresponding drug for treatment, and drug cardioversion curative effect was compared in four groups. Results The propafenone hydrochloride group had recovery rate as 80.00% and the amiodarone group had recovery rate as 73.33%, which were higher than 33.33% in verapamil hydrochloride group and 33.33% in lidocaine group, and differences had statistical significance（P〈0.05）. Conclusion Propafenone hydrochloride or amiodarone shows higher effect in the treatment of pre-excitation syndrome compound atrial fibrillation, and also can effectively recover sinus rhythm and save lives of patients.

关 键 词：预激综合征 心房颤动 

分 类 号：R541.7[医药卫生—心血管疾病]